Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_assertion type Assertion NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_head.
- NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_assertion description "[The data from the current study provide evidence that patients with HER2-positive breast cancer have a significantly higher incidence of CNS metastasis after treatment with trastuzumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_provenance.
- NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_assertion evidence source_evidence_literature NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_provenance.
- NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_assertion SIO_000772 21509760 NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_provenance.
- NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_assertion wasDerivedFrom befree-2016 NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_provenance.
- NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_assertion wasGeneratedBy ECO_0000203 NP888810.RA2uZG4-UGX4EodZwDPXIs8ifaFbNhGQ7dORvR69vyMgk130_provenance.